PNPLA2 and Hepatic steatosis: The latter develop mild liver steatosis, but this never progresses into inflammatory liver disease, supporting the hypothesis that ABHD5 regulates hepatic neutral lipid storage and inflammation via mechanisms not involving ATGL.